Multi-Omics Integration Analysis & Reporting Service
Creative Biolabs' service acts as a sophisticated bridge between raw sequencing outputs and actionable scientific insights. By vertically integrating DNA methylation (WGBS), chromatin accessibility (ATAC-seq), and protein-DNA interactions (ChIP-seq) with transcriptomics and proteomics, we provide a high-resolution, multi-dimensional map of the oncological landscape. Our methodology is specifically designed to overcome the "curse of dimensionality," allowing for the precise identification of distal enhancers, the discovery of novel prognostic signatures, and the elucidation of complex drug resistance mechanisms.
Background What We Can Offer Workflow Publication Why Choose Us FAQs Customer Review Related Services Contact Us
Introduction of Cancer Epigenetic Mapping
Cancer epigenetics involves heritable changes in gene expression that occur without altering the primary DNA sequence. Recent scientific reviews emphasize that integrating DNA methylation with 3D chromatin architecture and AI-based autoencoders is essential to navigate the inherent complexity of tumor biology. These integrative models have fundamentally transformed research pathology, and outcome prediction, offering a systematic approach to understanding the non-coding genome in the era of precision medicine. Creative Biolabs provides the specialized tools necessary to decode these regulatory switchboards and identify the next generation of epigenetic therapeutic targets.
Integrated Multi-Omic Solutions
Creative Biolabs provides an end-to-end analytical suite designed to extract maximal biological meaning from complex, multi-layered datasets. Our service modules include:
Comprehensive Epigenetic Landscape Mapping
We integrate DNA methylation, histone modification, and open chromatin data to define the regulatory state of the genome, uncovering the epigenetic switches that control gene expression across various oncological disease models.
3D Spatial Chromatin Analysis
Utilizing Hi-C technology and specialized AI algorithms, we map complex promoter-enhancer interactions, effectively linking functional non-coding variants to their respective target genes within a three-dimensional structural context.
Advanced Proteogenomic Correlation
We perform simultaneous analysis of the transcriptome and proteome to validate the functional consequences of epigenetic silencing, identifying high-confidence protein biomarkers that accurately reflect the underlying molecular phenotype.
AI-Driven Sample Stratification
Our team develops unsupervised machine learning models, such as autoencoders, to group biological samples into distinct molecular subtypes, capturing non-linear dependencies for superior classification compared to traditional methods.
Network-Based Target Prioritization
We construct intricate gene regulatory networks to identify critical "hub" regulators. These high-confidence targets are prioritized based on their roles as key drivers of oncogenesis and drug resistance.
Cloud-Native Bioinformatic Reporting
We deliver publication-ready visualizations, including OmicCircos maps and interaction networks, alongside detailed target prioritization dossiers, all hosted on scalable cloud platforms for seamless data exploration and sharing.
Explore Our Full Portfolio – Request a Custom Quote
Workflow
Creative Biolabs utilizes a structured, phased approach to manage multi-omics projects, ensuring that biological complexity is systematically reduced into actionable insights.
Publication
This review explores the integration of epigenetic data with other omics layers using artificial intelligence to advance precision medicine. It highlights how epigenetic mechanisms, such as DNA methylation and histone modifications, complement genetic insights and how AI techniques like deep learning enable multimodal analysis of complex biomedical data. The authors argue that such integrative approaches are essential to overcome current limitations and improve disease diagnosis, prognosis, and personalized treatment strategies.
Fig.1 A summary figure of epigenetic regulation and analysis technologies. 1
Why Choose Us?
Creative Biolabs stands at the intersection of biological expertise and advanced computational power. Unlike traditional service providers who offer siloed analysis, we provide an Intermediate Integration approach that respects the unique dynamic ranges of each platform while capturing the synergistic interactions between them. Our cloud-native infrastructure ensures seamless scalability for large-scale projects, utilizing CWL-based workflows and Docker containerization to guarantee 100% reproducibility. By leveraging unsupervised deep learning techniques, we capture non-linear dependencies that traditional models miss, resulting in superior sample stratification and outcome prediction in disease research.
Experience the Creative Biolabs Advantage - Schedule a Scientific Consultation
FAQs
How does Creative Biolabs handle data from different platforms with varying scales?
We employ intermediate integration techniques to normalize dynamic ranges across genomics, transcriptomics, and proteomics before fusion, ensuring no single layer biases the final model.
What makes your AI models superior to standard bioinformatics tools?
We utilize deep learning autoencoders and graph neural networks to capture complex, non-linear biological dependencies that traditional statistical tools often overlook.
Is the integrated analysis reproducible for project documentation?
Absolutely. All analytical steps are described in common workflow language (CWL) and executed within Docker containers, providing a transparent, reproducible trail.
Customer Review
-
Unprecedented Precision in Subtyping
Utilizing Creative Biolabs' integration service in our neuro-oncology research has significantly facilitated the subclassification of CNS tumor models. Their AI-driven methylation profiling clarified the molecular identity in 10% of our samples. – Dr. Marc* S
-
Non-coding Genome Clarity
We struggled with identifying functional non-coding SNPs in our research for years. Creative Biolabs' 3D chromatin mapping allowed us to link distal enhancers to oncogenes with high confidence. – Prof. Elen* W
Related Services
Single-cell Tools based Lineage Tracing Service
Creative Biolabs provides multimodal lineage tracing and sequencing. We integrate RNA-seq, ATAC-seq, and DNA methylation to decode tumor heterogeneity and resolve complex tissue dynamics.
Learn More →
Treg Subpopulation Expression Profiling
Creative Biolabs provides bulk and single-cell Treg profiling to decode immune regulation. We integrate RNA-seq, differential expression, and immunoinformatics to reveal functional mechanisms and therapeutic targets.
Learn More →
How to Contact Creative Biolabs
Creative Biolabs provides the most comprehensive multi-omics integration analysis and reporting service for cancer epigenetic mapping. By combining high-resolution wet-lab mapping with industry-leading AI, 3D connectivity analysis, and cloud-native computing, we empower you to decode the most complex layers of tumor biology and advance your therapeutic pipeline.
For detailed information or to discuss the specific requirements of your project, please contact our senior scientific team. We are ready to help you accelerate your next oncology breakthrough.
Reference
-
Hamamoto, R., et al. "Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine." Biomolecules 10.1 (2019). Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/biom10010062
For Research Use Only | Not For Clinical Use
Download our brochure